Drug-eluting stents enter periphery in U.S.

Article

While drug-eluting stents have proved successful in repairing coronary arteries, the periphery has been more challenging. The first FDA-approved clinical trial of a drug-coated stent for a peripheral artery began in October.

The DESTINY Trial will examine the effectiveness of the Zilver PTX drug-eluting stent in the above-the-knee femoropopliteal artery. The stent, made by Cook, is self-expanding and coated with the antitumor agent paclitaxel.

The trial will initially be conducted at 10 facilities and will enroll 60 patients. The Zilver PTX stent is 8 cm long, allowing for treatment of lesions up to 7 cm. A maximum of one drug-eluting stent will be implanted per patient. The trial will allow for another Zilver bare metal stent to be used in conjunction with the Zilver PTX if there is a dissection.

Results reported earlier this year from the first phase of the SIROCCO Trial conducted in Europe showed promise for the Cordis Smart sirolimus-eluting stent in the periphery. The stent was 8 cm long and 1 to 2 mm larger than the vessel diameter (6 to 7 mm). A maximum of three stents per patient were implanted. Investigators also determined that a slow-eluting rate is better than a faster one.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.